NCT00940212View on ClinicalTrials.gov

Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

80

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions

Healthy Volunteers

Interventions

DRUG

AZD2423

oral, single administration

DRUG

Placebo

oral administration and single dose

Trial Locations (1)

Unknown

Research Site, Berlin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY

NCT00940212 - Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 in Healthy Volunteers | Biotech Hunter | Biotech Hunter